By Editor, Global AgInvesting Media
Agricultural biotechnology company Moa Technology has secured £22.2 million in Series C financing to accelerate the development of its novel mode of action herbicides. The funding round was co-led by Oxford Science Enterprises (OSE) and Supernova Invest.
Expanding Investor Support
Spun out of the University of Oxford’s Plant Sciences Department in 2017, Moa’s main focus is on discovering innovative solutions to combat crop-killing weeds and support global food security. The round attracted new backers including Agri Investment Fund (AIF), GrainInnovate (managed by Artesian on behalf of the Grain Research Development Corporation), Infinity Investment Partners, and Magdalen College Oxford. Existing investors OSE, Lansdowne Partners, Parkwalk, and Oxford University Innovation also supported the financing.
“This marks a major milestone for Moa Technology — a validation of the outstanding progress we have made not just in the laboratory, but also in striking commercial deals with leading industry partners around the world,” said Dr. Virginia Corless, CEO of Moa Technology, in the press release.
“We are particularly pleased that, through AIF in Europe and GrainInnovate in Australia, the farming sector itself is closely connected to the next phase of Moa’s development, helping accelerate delivery of our solutions to the fields where they are so urgently needed.”
R&D Milestones and Commercial Alliances
Over the past 24 months, Moa has established R&D collaborations with major industry leaders, including Nufarm, Gowan, Certis Belchim, and Corteva Agriscience. Through its proprietary platforms, the company has screened over 900,000 compounds and discovered more than 80 novel mode of action areas capable of overriding existing weed resistance. In 2025, Moa introduced a distinct product category known as Moa Amplifiers™, which are designed to reduce the overall amount or concentration of herbicides required in farming operations.
Martin Fiennes of Oxford Science Enterprises commented, in the press release, on the company’s long-term progress: “When we helped spin Moa out from the University of Oxford’s Plant Sciences Department in 2017, we saw that its technology platform had a unique and important approach to address the market’s need for herbicides capable of breaking weed resistance. The success of the platform’s discoveries since in the lab and field trials has confirmed Moa is on track to provide the new solutions farmers need to sustain agricultural productivity, and we’re delighted to be supporting the company again in this fundraising round.”
Strategic Road to Commercialization
According to the organization, the newly raised capital should enable Moa to advance its three herbicide programs significantly closer to commercialization, expand its pipeline of early-stage discovery projects, and continue developing the Moa Amplifiers program. The equity funding will be complemented by upfront and milestone payments from current and future commercial partners.
“Weed resistance continues to spread,” noted Alexandre Biau of Supernova Invest. “It is causing increasing yield losses, further undermining the resilience of farming operations, while climate change is expected to make weed control even more challenging.
“In response, the Moa team is redefining the innovation playbook for weed control by advancing both novel modes of action and its Moa Amplifiers strategy, expanding the toolbox available to farmers,” Biau continued. “Building on the company’s strong momentum and proven ability to execute, Supernova Invest is proud to support Moa’s journey to market.”
The content put forth by Global AgInvesting News and its parent company Arc Network LLC is intended to be used and must be used for informational purposes only. All information or other material herein is not to be construed as legal, tax, investment, financial, or other advice. Global AgInvesting and Arc Network LLC are not a fiduciary in any manner, and the reader assumes the sole responsibility of evaluating the merits and risks associated with the use of any information or other content on this site.